CanSino Biologics Inc. ( CASBF) - Stock Earnings
CASBF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.9 million USD | 52.9 million USD |
| 2026Q1 | -5.8 million USD | 27.3 million USD |
| 2026Q2 | 5.8 million USD | 52.7 million USD |
| 2026Q4 Est. | — | — |
CASBF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -209.5 million USD | 48.8 million USD |
| 2024 | -51.9 million USD | 113.0 million USD |
| 2025 | 3.9 million USD | 147.5 million USD |
| 2026 Est. | — | — |
CASBF
Price: $3.35
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.02 USD
P/E Ratio: 230
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.4 billion